Since obesity and diabetes are key risk factors for cardiovascular disease, blocking the effects of NPY would not only have beneficial effects on local restenosis after arterial injury, but would also improve energy metabolism throughout the body, this reduced fat, a major potential cause of arteriosclerosis development and subsequent neointimal formation. The gene discussed is NPY; the disease is obesity due to melanocortin 4 receptor deficiency.